Russia Makes Breakthrough With Covid Nasal Spray
Russia’s Gamaleya National Research Center for Epidemiology and Microbiology, the team responsible for the Sputnik V vaccine, have stated they have completed the second phase of clinical tests of a nasal form of the coronavirus vaccine, and that ‘no side effects’ had been reported. President Putin has also said that he was one of the test subjects, with the spray being in powder form.
The spray’s efficacy – how effective it is amongst larger sectors of the population – has yet to be verified. Its use will probably be post-vaccination but as an alternative to a third booster shot.
Phase three trials are being carried out on a larger cross section of people. A Covid spray if successful could reach shops by late summer, although whether or not it will be used in other markets sch as the EU r elsewhere is dependent upon their preferences. The Sputnik V vaccine for example remains unauthorized for use in most the EU and the United States, where Governments prefer to give preference to vaccines produced by their own manufacturers and submit to political pressure to follow this protocol. Russia accepts most internationally produced vaccines for entry into the country as long as vaccine certificates and a negative PCR test can be provided.
Russia Briefing is written by Dezan Shira & Associates. The firm has 28 offices throughout Eurasia, including China, Russia, India, and the ASEAN nations, assisting foreign investors into the Eurasian region. Please contact Maria Kotova at firstname.lastname@example.org for Russian investment advisory or assistance with market intelligence, legal, tax and compliance issues throughout Asia.